Cristián Hernández-Cuevas

Cristián Hernández earned his degree in Molecular Biotechnology at Universidad de Chile and a Master in Bioscience Enterprise at the University of Cambridge, UK. He has developed his career around biotechnology businesses and technology transfer activities, both in Chile and the UK. Hernández has started several companies and has worked as a consultant for different firms and investment funds. In the UK he was Business Development Manager of Summit plc, a company listed in the London Stock Exchange. He has led multiple initiatives of scientific collaboration, like RedCiencia and the Encuentros Conference. In 2008, he joined Fundación Ciencia & Vida as its Chief Business Officer. Currently, he is also the CEO of Andes Biotechnologies a drug development company which focuses on the discovery of novel cancer therapies